These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39053620)

  • 1. Rewriting the textbook for pharma: how to adapt and thrive in a digital, personalized and collaborative world.
    Jones CH; Madhavan S; Natarajan K; Corbo M; True JM; Dolsten M
    Drug Discov Today; 2024 Sep; 29(9):104112. PubMed ID: 39053620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digitizing the Pharma Neurons - A Technological Operation in Progress!
    Bhardwaj P; Yadav RK; Kurian S
    Rev Recent Clin Trials; 2020; 15(3):178-187. PubMed ID: 32564760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.
    Martinez-Grau MA; Alvim-Gaston M
    Pharmaceut Med; 2019 Jun; 33(3):193-198. PubMed ID: 31933287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital health revolution: perfect storm or perfect opportunity for pharmaceutical R&D?
    Hird N; Ghosh S; Kitano H
    Drug Discov Today; 2016 Jun; 21(6):900-11. PubMed ID: 26821131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward precision health: applying artificial intelligence analytics to digital health biometric datasets.
    Cohoon TJ; Bhavnani SP
    Per Med; 2020 Jul; 17(4):307-316. PubMed ID: 32588726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Medicinal Chemistry Leaders in Industry (EMCL) - On the Status and Future of Medicinal Chemistry Research in Europe.
    Ali A; Bauser M; Bertrand S; Blackaby W; Boss C; Bossart M; Hall A; Binch H; Czechtizky W; Gijsen H; Haning H; Hartung IV; Kilburn P; Lassalle G; Lücking U; Mack J; Missbach M; Otsomaa L; Torrens A; Wagner M; Walter M; Weinstabl H; van Hijfte L; von Nussbaum F
    ChemMedChem; 2023 Jul; 18(13):e202300127. PubMed ID: 37276375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics.
    Khatab Z; Yousef GM
    Crit Rev Clin Lab Sci; 2021 Dec; 58(8):546-562. PubMed ID: 34297653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlocking the full potential of digital endpoints for decision making: a novel modular evidence concept enabling re-use and advancing collaboration.
    Leyens L; Batchelor J; De Beuckelaer E; Langel K; Hartog B
    Expert Rev Pharmacoecon Outcomes Res; 2024 Jul; 24(6):731-741. PubMed ID: 38747565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engaging Through Awareness: Purpose-Driven Framework Development to Evaluate and Develop Future Business Strategies With Exponential Technologies Toward Healthcare Democratization.
    Barbazzeni B; Haider S; Friebe M
    Front Public Health; 2022; 10():851380. PubMed ID: 35692334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative university-industry R&D practices supporting the pharmaceutical innovation process: Insights from a bibliometric review.
    Ma Z; Augustijn K; de Esch IJP; Bossink B
    Drug Discov Today; 2022 Aug; 27(8):2333-2341. PubMed ID: 35550437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leading a Digital Transformation in the Pharmaceutical Industry: Reimagining the Way We Work in Global Drug Development.
    Finelli LA; Narasimhan V
    Clin Pharmacol Ther; 2020 Oct; 108(4):756-761. PubMed ID: 32294230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence for Pharma: Time for Internal Investment.
    Henstock PV
    Trends Pharmacol Sci; 2019 Aug; 40(8):543-546. PubMed ID: 31204059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
    Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
    Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Navigating the Digital Landscape: Embracing Innovation, Addressing Challenges, and Prioritizing Patient-Centric Care.
    Vats K
    Cureus; 2024 Apr; 16(4):e58352. PubMed ID: 38756283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and emerging technology for adult social care - the example of home sensors with artificial intelligence (AI) technology.
    Glasby J; Litchfield I; Parkinson S; Hocking L; Tanner D; Roe B; Bousfield J
    Health Soc Care Deliv Res; 2023 Jun; 11(9):1-64. PubMed ID: 37470136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors.
    Cova T; Vitorino C; Ferreira M; Nunes S; Rondon-Villarreal P; Pais A
    Methods Mol Biol; 2022; 2390():321-347. PubMed ID: 34731476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing pharmacy and healthcare with virtual digital technologies.
    Trenfield SJ; Awad A; McCoubrey LE; Elbadawi M; Goyanes A; Gaisford S; Basit AW
    Adv Drug Deliv Rev; 2022 Mar; 182():114098. PubMed ID: 34998901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.